Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 14,124 shares at $27.00 ($382K) on 2025-05-07, disclosed to the SEC on 2025-05-09.
Scheduled sale ($382k) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 1,965 | $53K | 13.9% |
| 2 | $27.00 | 101 | $3K | 0.7% |
| 3 | $27.05 | 6,029 | $163K | 42.7% |
| 4 | $27.05 | 6,029 | $163K | 42.7% |
| Total | $27.04 avg | 14,124 | $382K | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |